Pancreatic cancer: 4-drug chemo regimen shows promise in improving survival rates

Dr. Anton Bilchik, surgical oncologist and chief of medicine and Director of the Gastrointestinal and Hepatobiliary Program at Providence Saint John’s Cancer Institute in Santa Monica, CA, told Medical News Today:

“Pancreas cancer is one of the most chemotherapy-resistant tumors. One of the reasons is that it is typically surrounded by a thickened scar (fibrosis) which makes chemotherapy penetration difficult. Another reason is that the majority of patients with pancreas cancer present with advanced disease at a point where it has already spread.”

Read the full article on Medical News Today